EYENOVIA INC. - COMMO
0.0889
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.0187
-17.38%
Today's range
0.0790 - 0.0984
ISIN
N/A
Source
NASDAQ
-
Eyenovia Announces $12 Million Registered Direct Offering
24 Aug 2023 18:47:29 By Nasdaq GlobeNewswire
-
16 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update
10 Aug 2023 16:05:01 By Nasdaq GlobeNewswire
-
Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
09 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10
07 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
Eyenovia Announces First Commercial Sale of Mydcombi™
03 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes
26 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Announces Presentation at the OCTANE Ophthalmology Tech Forum 2023
01 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update
11 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
08 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia to Report First Quarter 2023 Results on Thursday, May 11
04 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Announces Poster Presentation at ARVO 2023
24 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update
30 Mar 2023 16:05:01 By Nasdaq GlobeNewswire
-
Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30
23 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
28 Feb 2023 16:05:01 By Nasdaq GlobeNewswire
-
Eyenovia Announces Development Collaboration Agreement with Formosa Pharmaceuticals
15 Feb 2023 09:51:05 By Nasdaq GlobeNewswire
-
12 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Announces Participation at the 2023 International Consumer Electronics Show
20 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation
13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire
-
Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President
08 Dec 2022 08:00:01 By Nasdaq GlobeNewswire